NEUPHORIA THERAPEUTICS INC
NEUPNASDAQ🏆 #4649 by market capEarnings Nov 12US Equity
$3.37▼ $0.17 (−4.80%)
Pre-market · at closeTrack NEUP
Get earnings, price moves & breaking news on Telegram
24h▼ 4.8%
7d▼ 3.4%
14d▲ 0.6%
30d▼ 7.4%
ytd▼ 11.8%
1y▼ 27.0%
🏦Market Cap
$18M
Small Cap
📈Revenue Growth (YoY)
-92.5%
Declining
📊Gross Margin
43.5%
Healthy
💵FCF Margin
-1052118.7%
Thin
⚖️P/S Ratio
15.5x
Expensive
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $3.37 – $3.37
- 52-Week Range
- $3.19 – $5.53
- Volume (shares)
- 200
- Avg Volume (shares)
- —
- Shares Outstanding
- 5.4M
- Next Earnings
- 2026-11-12
Fundamentals Snapshot
- Annual Revenue
- $1M
- Last Q Revenue
- $1M
- P/E Ratio
- -0.5
- P/S Ratio
- 15.5x
- EPS (TTM)
- $-3.42
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +19.3%
NEUPHORIA THERAPEUTICS INC
NEUPFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1M▼ −92.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
43.5%▼ −54.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$10M▲ +768.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$12.4B▼ −16095.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.4M▲ +19.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$20M▼ −$2M YoY
StockOtter · stockotter.spaceAbout NEUPHORIA THERAPEUTICS INC
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.